Systems, devices and methods for anti-TL1A therapy

• 收藏
• 分享

专利权人:

Cedars-Sinai Medical Center

发明人:

Targan, Stephan R.,Gonsky, Rebecca,Deem, Richard

申请号：

AU2014317991

公开号：

AU2014317991A1

申请日:

2014.09.05

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

The present invention relates to biomarker genes for diagnosing and treating diseases. Provided herein are systems and methods of diagnosing a disease in a patient based on the patient's expression levels of biomarker genes. Examples of the TL1A-associated disease include, but are not limited to, an inflammatory bowel disease (IBD), Crohn's disease (CD), ulcerative colitis (UC), and fibrosis. Also provided herein are systems and methods of identifying a patient likely to be responsive to an anti-TL1A therapy, prescribing and/or administrating an anti-TL1A therapy to the patient based on the patient's expression levels of biomarker genes.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/